Works matching DE "INFLIXIMAB"

Results: 3321

The Effects of the Biological Agents Infliximab, Vedolizumab, and Ustekinumab on Intestinal Anastomosis: An Experimental Study in Rats.

Published in:

Biomedicines, 2025, v. 13, n. 5, p. 1079, doi. 10.3390/biomedicines13051079

By:

Menni, Alexandra;
Tzikos, Georgios;
Goulas, Patroklos;
Chatziantoniou, George;
Vouchara, Angeliki;
Apostolidis, Athanasios S.;
Ioannidis, Aristeidis;
Germanidis, Georgios;
Papazoglou, Lyssimachos G.;
Giouleme, Olga;
Apostolidis, Stylianos

Publication type:

Article

Rapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab.

Published in:

Pediatric Dermatology, 2025, v. 42, n. 3, p. 603, doi. 10.1111/pde.15828

By:

Perry, Nikhita J.;
Wang, Stephanie;
Smith, Robert;
Duffy, Robert;
Queenan, Maria;
Perman, Marissa J.;
Lerman, Melissa A.;
Larijani, Mary

Publication type:

Article

Treatment choices, preferences and decision-making by patients with rheumatoid arthritis.

Published in:

Musculoskeletal Care, 2008, v. 6, n. 1, p. 1, doi. 10.1002/msc.110

By:

Chilton, Frances;
Collett, Raymond A.

Publication type:

Article

The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.

Published in:

2018

By:

de S. B. Fróes, Renata;
Carvalho, Ana Teresa Pugas;
de V. Carneiro, Antonio Jose;
de Barros Moreira, Adriana Maria Hilu;
Moreira, Jessica P. L.;
Luiz, Ronir R.;
de Souza, Heitor S.

Publication type:

journal article

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.

Published in:

European Journal of Health Economics, 2014, v. 15, p. 53, doi. 10.1007/s10198-014-0594-4

By:

Baji, Petra;
Péntek, Márta;
Czirják, László;
Szekanecz, Zoltán;
Nagy, György;
Gulácsi, László;
Brodszky, Valentin

Publication type:

Article

Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries.

Published in:

European Journal of Health Economics, 2014, v. 15, p. 65, doi. 10.1007/s10198-014-0595-3

By:

Brodszky, Valentin;
Baji, Petra;
Balogh, Orsolya;
Péntek, Márta

Publication type:

Article

Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis.

Published in:

European Journal of Health Economics, 2010, v. 11, n. 1, p. 67, doi. 10.1007/s10198-009-0199-5

By:

Punekar, Yogesh Suresh;
Hawkins, Neil

Publication type:

Article

The Surgical Options and Management of Intestinal Crohn's Disease.

Published in:

Indian Journal of Surgery, 2011, v. 73, n. 6, p. 432, doi. 10.1007/s12262-011-0319-1

By:

Chandra, Raaj;
Moore, James

Publication type:

Article

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 891, doi. 10.1007/s00228-022-03294-2

By:

Cheli, Stefania;
Cozzi, Valeria;
Cattaneo, Dario;
Norsa, Lorenzo;
De Giacomo, Costantino;
Clementi, Emilio;
Moretti, Chiara

Publication type:

Article

Correction to: Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 2, p. 273, doi. 10.1007/s00228-020-02989-8

By:

Dave, Mihika B.;
Dherai, Alpa J.;
Desai, Devendra C.;
Mould, Diane R.;
Ashavaid, Tester F.

Publication type:

Article

Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 1, p. 55, doi. 10.1007/s00228-020-02975-0

By:

Dave, Mihika B.;
Dherai, Alpa J.;
Desai, Devendra C.;
Mould, Diane R.;
Ashavaid, Tester F.

Publication type:

Article

The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 1, p. 35, doi. 10.1007/s00228-019-02765-3

By:

Jensen, Thomas Bo;
Bartels, Dorthe;
Sædder, Eva Aggerholm;
Poulsen, Birgitte Klindt;
Andersen, Stig Ejdrup;
Christensen, Mette Marie H.;
Nielsen, Lars;
Christensen, Hanne Rolighed

Publication type:

Article

Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients—a case-control study.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 10, p. 1445, doi. 10.1007/s00228-019-02715-z

By:

van Wassenaer, Elsa A.;
Meester, Veronique L.;
Kindermann, Angelika;
Koot, Bart G. P.;
Benninga, Marc A.;
de Meij, Tim G. J.

Publication type:

Article

The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease.

Published in:

2018

By:

Pineles, David;
Malter, Lisa;
Liang, Peter S.;
Arsuaga, Amy;
Bosworth, Brian;
Hudesman, David P.;
Chang, Shannon

Publication type:

Letter to the Editor

Non-specific treatment effects and the patient perception of costly drug therapy.

Published in:

2018

By:

Boone, N. W.

Publication type:

Letter to the Editor

The nocebo effect challenges the non-medical infliximab switch in practice.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 5, p. 655, doi. 10.1007/s00228-018-2418-4

By:

Boone, N. W.;
Liu, L.;
Romberg-Camps, M. J.;
Duijsens, L.;
Houwen, C.;
van der Kuy, P. H. M.;
Janknegt, R.;
Peeters, R.;
Landewé, R. B. M.;
Winkens, B.;
van Bodegraven, A. A.

Publication type:

Article

Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 12, p. 1523, doi. 10.1007/s00228-017-2325-0

By:

Fortuna, Giulio;
Aria, Massimo;
Schiavo, Julie

Publication type:

Article

Network meta-analysis as a tool for improving the effectiveness assessment of biosimilars based on both direct and indirect evidence: application to infliximab in rheumatoid arthritis.

Published in:

2017

By:

Messori, Andrea;
Trippoli, Sabrina;
Marinai, Claudio

Publication type:

Letter

A robust estimation of infliximab pharmacokinetic parameters in Crohn's disease.

Published in:

2015

By:

Aubourg, Alexandre;
Picon, Laurence;
Lecomte, Thierry;
Bejan-Angoulvant, Theodora;
Paintaud, Gilles;
Ternant, David

Publication type:

Letter

Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 3, p. 431, doi. 10.1007/s00228-012-1389-0

By:

Lacruz-Guzmán, Diana;
Torres-Moreno, Daniel;
Pedrero, Francisco;
Romero-Cara, Patricia;
García-Tercero, Iván;
Trujillo-Santos, Javier;
Conesa-Zamora, Pablo

Publication type:

Article

A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitis.

Published in:

European Journal of Clinical Pharmacology, 2011, v. 67, n. 8, p. 759, doi. 10.1007/s00228-011-1079-3

By:

Huang, Xuan;
Lv, Bin;
Jin, Hai-feng;
Zhang, Shuo

Publication type:

Article

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 12, p. 1211, doi. 10.1007/s00228-009-0718-4

By:

Fasanmade, Adedigbo A.;
Adedokun, Omoniyi J.;
Ford, Joyce;
Hernandez, Danika;
Johanns, Jewel;
Chuanpu Hu;
Davis, Hugh M.;
Honghui Zhou

Publication type:

Article

Structure-based development and optimization of therapy antibody drugs against TNFα.

Published in:

Amino Acids, 2015, v. 47, n. 6, p. 1259, doi. 10.1007/s00726-015-1954-9

By:

Fu, Wenyan;
Wang, Xiaoze;
Yang, Weili;
Takeda, Hiroaki;
Hu, Shi;
Lou, Zhiyong;
Zhao, Jian;
Bethune, Augus;
Guo, Yajun

Publication type:

Article

Pregnancy-Induced Sweet's Syndrome Treated with Infliximab.

Published in:

2019

By:

Smolovic, Brigita D.;
Gajic-Veljic, Mirjana D.;
Nikolic, Milos M.;
Muhovic, Damir F.;
Smolovic, Brigita D;
Gajic-Veljic, Mirjana D;
Nikolic, Milos M;
Muhovic, Damir F

Publication type:

Case Study

Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.

Published in:

Digestive Diseases, 2021, v. 39, n. 1, p. 1, doi. 10.1159/000508069

By:

Mateos, Beatriz;
Sáez-González, Esteban;
Moret, Inés;
Hervás, David;
Iborra, Marisa;
Cerrillo, Elena;
Tortosa, Luis;
Nos, Pilar;
Beltrán, Belén

Publication type:

Article

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.

Published in:

Digestive Diseases, 2019, v. 37, n. 2, p. 108, doi. 10.1159/000492626

By:

Beltrán, Belén;
Iborra, Marisa;
Sáez-González, Esteban;
Marqués-Miñana, Maria R.;
Moret, Inés;
Cerrillo, Elena;
Tortosa, Luis;
Bastida, Guillermo;
Hinojosa, Joaquín;
Poveda-Andrés, Jose Luis;
Nos, Pilar

Publication type:

Article

Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion Reactions.

Published in:

Digestive Diseases, 2018, v. 36, n. 6, p. 417, doi. 10.1159/000491078

By:

Pauchard, Isabelle;
Nancey, Stéphane;
Hacard, Florence;
Williet, Nicolas;
Roblin, Xavier;
Moussata, Driffa;
Bérard, Frédéric;
Flourié, Bernard;
Boschetti, Gilles

Publication type:

Article

Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.

Published in:

Digestive Diseases, 2018, v. 36, n. 2, p. 106, doi. 10.1159/000481815

By:

Takeuchi, Ken;
Shimoyama, Takahiro;
Yamamoto, Takayuki

Publication type:

Article

Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors.

Published in:

Digestive Diseases, 2018, v. 36, n. 1, p. 40, doi. 10.1159/000477962

By:

Ohem, Jan;
Hradsky, Ondrej;
Zarubova, Kristyna;
Copova, Ivana;
Bukovska, Petra;
Prusa, Richard;
Malickova, Karin;
Bronsky, Jiri

Publication type:

Article

Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 40, doi. 10.1159/000477962

By:

Ohem, Jan;
Hradsky, Ondrej;
Zarubova, Kristyna;
Copova, Ivana;
Bukovska, Petra;
Prusa, Richard;
Malickova, Karin;
Bronsky, Jiri

Publication type:

Article

Infliximab Therapy Improves the Bone Metabolism in Fistulizing Crohn’s Disease.

Published in:

Digestive Diseases, 2006, v. 24, n. 1/2, p. 201, doi. 10.1159/000091299

By:

Miheller, Pal;
Müzes, Gyorgyi;
Zagoni, Tamas;
Toth, Miklos;
Racz, Karoly;
Tulassay, Zsolt

Publication type:

Article

Emerging Biological Treatments in Inflammatory Bowel Diseases.

Published in:

Digestive Diseases, 2006, v. 24, n. 1/2, p. 131, doi. 10.1159/000090316

By:

Van Assche, Gert;
Vermeire, Séverine;
Rutgeerts, Paul

Publication type:

Article

Standard Treatment of Ulcerative Colitis.

Published in:

Digestive Diseases, 2003, v. 21, n. 2, p. 157, doi. 10.1159/000073247

By:

Gionchetti, Paolo;
Rizzello, Fernando;
Habal, Flavio;
Morselli, Claudia;
Amadini, Cristina;
Romagnoli, Rossella;
Campieri, Massimo

Publication type:

Article

Standard Therapy of Crohn's Disease.

Published in:

Digestive Diseases, 2003, v. 21, n. 2, p. 146, doi. 10.1159/000073246

By:

Miehsler, Wolfgang;
Gasche, Christoph

Publication type:

Article

Comparison of Survival and Retention Rates between Infliximab and Adalimumab for Psoriasis: 10-Year Experience at a Single Tertiary Center.

Published in:

Dermatology (10188665), 2023, v. 239, n. 3, p. 355, doi. 10.1159/000529964

By:

Onsun, Nahide;
Güneş, Begüm;
Kaya, Gökhan;
Güçkan Işık, Bengisu;
Yabacı Tak, Ayşegül

Publication type:

Article

Local Perfusion of the Tumor Necrosis Factor α Blocker Infliximab to the Inner Ear Improves Autoimmune Neurosensory Hearing Loss.

Published in:

Audiology & Neurotology, 2006, v. 11, n. 6, p. 357, doi. 10.1159/000095897

By:

Van Wijk, F.;
Staecker, H.;
Keithley, E.;
Lefebvre, P. P.

Publication type:

Article

Patients with Ankylosing Spondylitis Can Maintain Clinical and Functional Improvement after Switching from Infliximab Reference Product to Infliximab Biosimilar (REMSIMA): 12 Months Comparative Open-Label Study.

Published in:

Journal of Clinical Rheumatology & Immunology (JCRI), 2022, v. 22, n. 2, p. 67, doi. 10.1142/S266134172250002X

By:

Mathkhor, Abdulsatar J.;
Altaqi, Ali;
Abdullah, Abdulnasser;
Khudhairy, Amer

Publication type:

Article

Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis.

Published in:

JAMA Network Open, 2024, v. 7, n. 6, p. e2418800, doi. 10.1001/jamanetworkopen.2024.18800

By:

Peng, Kuan;
Chan, Shirley C. W.;
Wang, Yang;
Cheng, Franco W. T.;
Yeung, Winnie W. Y.;
Jiao, Yuanshi;
Chan, Esther W. Y.;
Wong, Ian C. K.;
Lau, Chak-Sing;
Li, Xue

Publication type:

Article

Current and Emerging Targeted Therapies for Ulcerative Colitis.

Published in:

Visceral Medicine, 2023, v. 39, n. 2, p. 46, doi. 10.1159/000530983

By:

Pietschner, Robert;
Rath, Timo;
Neurath, Markus F.;
Atreya, Raja

Publication type:

Article

Stopping Anti-TNF in CD Remitters: Cons.

Published in:

Inflammatory Intestinal Diseases, 2022, v. 7, n. 1, p. 59, doi. 10.1159/000517961

By:

Kobayashi, Taku

Publication type:

Article

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 956, doi. 10.3390/jcm8070956

By:

Kaltsonoudis, Evripidis;
Pelechas, Eleftherios;
Voulgari, Paraskevi V.;
Drosos, Alexandros A.

Publication type:

Article

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 956, doi. 10.3390/jcm8070956

By:

Kaltsonoudis, Evripidis;
Pelechas, Eleftherios;
Voulgari, Paraskevi V.;
Drosos, Alexandros A.

Publication type:

Article

Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 5, p. 751, doi. 10.3390/jcm8050751

By:

Rinaudo-Gaujous, Mélanie;
Blasco-Baque, Vincent;
Miossec, Pierre;
Gaudin, Philippe;
Farge, Pierre;
Roblin, Xavier;
Thomas, Thierry;
Paul, Stephane;
Marotte, Hubert

Publication type:

Article

Extraction of Electronic Health Record Data in a Hospital Setting: Comparison of Automatic and Semi-Automatic Methods Using Anti- TNF Therapy as Model.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 112, n. 6, p. 392, doi. 10.1111/bcpt.12055

By:

Cars, Thomas;
Wettermark, Björn;
Malmström, Rickard E.;
Ekeving, Gunnar;
Vikström, Bo;
Bergman, Ulf;
Neovius, Martin;
Ringertz, Bo;
Gustafsson, Lars L.

Publication type:

Article

Chronic Administration of Infliximab (TNF-α Inhibitor) Decreases Depression and Anxiety-like Behaviour in Rat Model of Chronic Mild Stress.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 112, n. 5, p. 335, doi. 10.1111/bcpt.12037

By:

Karson, Ayşe;
Demirtaş, Tuğçe;
Bayramgürler, Dilek;
Balcı, Fuat;
Utkan, Tijen

Publication type:

Article

Palliative treatment of anal fistulas in Crohn's disease.

Published in:

ANZ Journal of Surgery, 2016, v. 86, n. 3, p. 148, doi. 10.1111/ans.13474

By:

Hermann, Jacek;
Eder, Piotr;
Banasiewicz, Tomasz;
Kołodziejczak, Barbara;
Łykowska‐Szuber, Liliana

Publication type:

Article

Pulmonary aspergillosis after treatment with infliximab in Still's disease and a literature review of Still's disease and pulmonary aspergillosis.

Published in:

European Journal of Rheumatology, 2018, v. 5, n. 1, p. 155, doi. 10.5152/eurjrheum.2016.15081

By:

Şeyhoğlu, Emrah;
Erden, Abdülsamet;
Kılıç, Levent;
Karadağ, Ömer;
Akdağlı, Sevtap Arıkan;
Akdoğan, Ali;
Kalyoncu, Umut

Publication type:

Article

Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

Published in:

European Journal of Rheumatology, 2018, v. 5, n. 1, p. 83, doi. 10.5152/eurjrheum.2017.17068

By:

Sho Ueda;
Mitsuteru Akahoshi;
Atsunobu Takeda;
Yasushi Inoue;
Aya Omoto;
Masahiro Ayano;
Yasutaka Kimoto;
Hiroki Mitoma;
Yojiro Arinobu;
Hiroaki Niiro;
Hiroshi Tsukamoto;
Takahiko Horiuchi;
Shin-Ichi Hikita;
Takako Fukuhara;
Tatsuro Ishibashi;
Koh-Hei Sonoda;
Koichi Akashi

Publication type:

Article

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet's disease after switching from infliximab originator.

Published in:

2017

By:

Cantini, Fabrizio;
Niccoli, Laura;
Nannini, Carlotta;
Cassara, Emanuele;
Kaloudi, Olga

Publication type:

Case Study

Successful treatment of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with tocilizumab: A case report.

Published in:

2015

By:

Akasbi, Nessrine;
Soyfoo, Muhammad S.

Publication type:

Case Study